Miridesap
Miridesap (GSK2315698) is a divalent cross-linking agent that rapidly depletes serum amyloid P component (SAP) from circulation through hepatic clearance, while also reducing SAP levels in cerebrospinal fluid and visceral amyloid deposits. It is utilized in in vivo research models of systemic amyloidosis to study amyloid dissolution and clearance mechanisms.
Product Specifications
CAS Number
224624-80-0
Product Name Alternative
CPHPC, GSK 2315698, GSK2315698, GSK-2315698, Inhibitor, Miridesap, inhibit, Ro63-8695
Field of Research
Neuroscience
Purity
≥95% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (5.88 mM) ; DMSO:75 mg/mL (220.35 mM)
Smiles
C (CCCCC (=O) N1[C@@H] (C (O) =O) CCC1) (=O) N2[C@@H] (C (O) =O) CCC2
Molecular Formula
C16H24N2O6
Molecular Weight
340.37
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
bs-5328R-BF555 100 µL
5HT3C Polyclonal Antibody, AbBy Fluor™ 555 Conjugated
Sign In for Pricing
View Details 125492 50 µg
CX3CR1 (Beta Chemokine Receptor-like 1, CCRL1, Chemokine C-X3-C Motif Receptor 1, CX3C Chemokine Receptor 1, C-X3-C CKR-1, CX3C CKR-1, CMK-BRL-1, CMKBLR1, CMKDR1, Fractalkine Receptor, GPR13, GPRV28, V28)
Sign In for Pricing
View Details 